BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24720475)

  • 21. Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II.
    El-Feky SA; Abd El-Samii ZK; Osman NA; Lashine J; Kamel MA; Thabet HKh
    Bioorg Chem; 2015 Feb; 58():104-16. PubMed ID: 25590381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents.
    Ragab FA; Abdel Gawad NM; Georgey HH; Said MF
    Eur J Med Chem; 2013 May; 63():645-54. PubMed ID: 23567953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
    Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
    Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New substituted pyrazole derivatives targeting COXs as potential safe anti-inflammatory agents.
    Abdellatif KR; El-Saadi MT; Elzayat SG; Amin NH
    Future Med Chem; 2019 Aug; 11(15):1871-1882. PubMed ID: 31517535
    [No Abstract]   [Full Text] [Related]  

  • 26. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
    Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
    Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
    Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
    Firke SD; Bari SB
    Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.
    Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA
    Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
    Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
    Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
    El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM
    Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
    Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
    Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors.
    Abdur Rahim M; Praveen Rao PN; Bhardwaj A; Kaur J; Huang Z; Knaus EE
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6074-80. PubMed ID: 21890358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; ElTahir KE
    Bioorg Med Chem; 2012 May; 20(10):3306-16. PubMed ID: 22516672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents.
    Manivannan E; Chaturvedi SC
    Bioorg Med Chem; 2011 Aug; 19(15):4520-8. PubMed ID: 21724403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of novel pyrazole compounds.
    Youssef AM; Neeland EG; Villanueva EB; White MS; El-Ashmawy IM; Patrick B; Klegeris A; Abd-El-Aziz AS
    Bioorg Med Chem; 2010 Aug; 18(15):5685-96. PubMed ID: 20609589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents.
    Bekhit AA; Fahmy HT; Rostom SA; El-Din A Bekhit A
    Eur J Med Chem; 2010 Dec; 45(12):6027-38. PubMed ID: 20970223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, characterization and anti-inflammatory evaluation of novel pyrazole amalgamated flavones.
    Chavan HV; Bandgar BP; Adsul LK; Dhakane VD; Bhale PS; Thakare VN; Masand V
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1315-21. PubMed ID: 23357629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazole-based chalcones.
    Chavan HV; Adsul LK; Kotmale AS; Dhakane VD; Thakare VN; Bandgar BP
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):22-31. PubMed ID: 24666306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity.
    Tewari AK; Srivastava P; Singh VP; Singh A; Goel RK; Mohan CG
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):634-8. PubMed ID: 20460788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.